PHD Discussions Logo

Ask, Learn and Accelerate in your PhD Research

Question Icon Post Your Answer

Question Icon

How does age affect the use of atropine in clinical settings?

I'm analyzing how core principles of geropharmacology apply to autonomic drugs. The question moves beyond simple dosing to how age-related changes in body composition, receptor sensitivity, and homeostatic mechanisms should reshape our entire clinical strategy for agents with systemic effects.

 

All Answers (1 Answers In All)

By Fathima M Answered 5 years ago

Age alters the game on two key fronts. Pharmacokinetically, reduced lean body mass and renal function lead to higher, prolonged drug levels. More critically, pharmacodynamically, I've observed that the elderly have a diminished autonomic response, making them paradoxically more sensitive to atropine's side effects like tachycardia, while also being more vulnerable to its central anticholinergic effects. You're not just giving a drug; you're intervening in a system with less buffer.

 

Your Answer